Bloomberg Originals
@business·5.1M subscribers·49.5K videos
Valeant Calls Short Seller's Report 'Erroneous'
Posted
October 21, 2015
Views
2,150
Likes
5
Engagement
0.23%
October 21, 2015
2,150
5
0.23%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
3:25Now PlayingOct. 21 -- Valeant Pharmaceuticals International Inc. called a short seller’s report that it used a strategy of recording fake sales to phony customers “erroneous” and defended its relationship with specialty pharmacies that distribute its drugs. Bloomberg's Drew Armstrong reports on "Bloomberg Markets."
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
